Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of August 2024. The report specifically details a transaction in the company's own shares executed on August 29, 2024, under a share buyback programme announced on August 1, 2024.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the specific share repurchase transaction:
- Shares Purchased: 324,289 ordinary shares
- Highest Price Paid: 377.80 pence per share
- Lowest Price Paid: 374.00 pence per share
- Volume Weighted Average Price: 375.5781 pence per share
- Post-Transaction Share Capital: 9,123,949,245 ordinary shares
Material Changes
The primary material change reported is the reduction of the company's registered share capital following the cancellation of the 324,289 purchased shares. No other material changes to operations or financial position are disclosed in this specific filing.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies beyond the standard disclosure that the announcement does not constitute an offer for securities. It references the Market Abuse Regulation (EU) No 596/2014 regarding the availability of a full trade breakdown.
Key Facts for Investor Verification
- Verify the total number of shares repurchased to date under the August 1, 2024 Buyback Programme.
- Confirm the updated total share capital of 9,123,949,245 ordinary shares for disclosure threshold calculations.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular transaction details.
- Note that this filing is a transaction report and does not contain quarterly or annual financial performance data.